Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 827 in Psoriasis
NCT01101100Phase 2Terminated
- Sponsor
- Valeant Pharmaceuticals
- Start
- Apr 2010
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of brodalumab in plaque psoriasis, sponsored by Valeant Pharmaceuticals. Started Apr 2010; status: terminated.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01101100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101100.